Tags

,

Stacey MayStacey May is the AAPS director of Public Outreach.

Greetings from San Diego, CA, where the AAPS National Biotechnology (NBC) attendees are beginning to head back to their organizations very much energized from this innovative and thought-provoking meeting!

With over 1,300 in attendance, many of the sessions were standing room only, including our hot hot topic session on the recently released FDA draft immunogenicity guidance. Drs. Leroy Hood, Mina Bissell, and Anton Simeonov provided inspiring plenary session presentations on such varied topics as proactive P4 medicine, novel ways to approach breast cancer research, and the effective use of collaboration within government-sponsored research. Additional sessions on subcutaneous administration of biologics as an immunogenicity risk factor, quantitative evaluation on the impact of immunogenicity on the pharmacokinetics and pharmacodynamics and efficacy of therapeutic proteins, and development of biospecific antibodies were very well attended. 13_NBC2_blogEDIT

Networking was the name of the game here, with conference rooms and hallways filled with animated discussions. The BioTalk sessions, held both outside and within the pavilion area, have become a unique feature of the meeting. Exhibits were another huge draw, with over 120 companies represented (two receptions in the exhibit area didn’t hurt either!). And with nearly 300 posters, the 2013 NBC meeting attendees had access to the most cutting-edge research in pharmaceutical biotechnology.

The job boards also continue to be a very popular attraction, with over 40 positions available for review. Bolstered by the ever-popular mentoring breakfast-where 90 young professionals and mentors gathered to discuss all manner of professional development issues-attendees eagerly interacted with colleagues to identify new career opportunities.

The 2014 NBC Planning Committee is hard at work on next year’s meeting and welcomes your programming suggestions. What would you like to see at that meeting?